All G is gearing up to launch its first product—recombinant bovine lactoferrin—in Q1 2026, says CEO Jan Pacas.

If you have been wondering whether Ono Pharmaceutical is still a smart buy at today’s price, you are not alone, and this article is going to unpack what the current share price really implies about ...

Wondering whether Icahn Enterprises at around $7.73 is a bargain or a value trap? This article will walk through the numbers so you can decide with confidence. The stock is down about 4.4% over the ...